(Sharecast News) - Shares in medical device group Convatec dipped on Wednesday after the FTSE 100 firm revealed that a hunt for a new chief financial is underway following the exit of Fiona Ryder after just eight months in the role.
Ryder, who joined Convatec in early 2022 as group financial controller, was appointed as interim CFO in August 2025 before stepping into the permanent position in November.

However, the company said she will now stand down as CFO but stay on until a successor has been appointed.

In a statement, Convatec said Ryder had made a "substantial contribution" to the company, including her work in transforming the finance function and launching its first $500m investment-grade bond and its first share buyback programme.

"[Ryder] stepped into the role of CFO in 2025 at a challenging time for the business, and has ensured that we didn't miss a step as we transitioned to our new Accelerate strategy," said chief executive Jonny Mason.

"We are very grateful for her continued leadership, commitment and support through the transition period."

In a brief update, Convatec said results for the six months to 30 June will be in line with expectations, as it remains on track to deliver double-digit growth in adjusted earnings per share in 2026. Organic growth should be 5-7%, while the adjusted operating margin is expected to be at least 23%.

The stock was down 0.9% at 208.8p by 0838 BST.

See the latest RNS on Investegate.

• News Channel